U.S. News & World Report has ranked National Jewish Medical and Research Center the #1 Respiratory Hospital in the United States since 1998. Today, National Jewish is also renowned worldwide as a leader in groundbreaking biomedical research of respiratory, immunologic, allergic and infectious diseases. The Clinical Reference Laboratories at National Jewish provide cutting edge and unique assays in all of these disciplines for clients throughout the world. National Jewish was founded in 1899 as a nonprofit, nonsectarian hospital for patients with tuberculosis and has matured to its current status as a world-class healthcare and research organization.

For more information, please visit our website at www.nationaljewish.org/research/research/index.aspx.

• Diagnostic Immunology and Flow Cytometry
  Offers comprehensive panels of assays, which measure and determine the functional activities of antibodies, immunoglobulins, neutrophils and lymphocytes. Assays are also available to evaluate phagocytic activity including chemotaxis, oxidative metabolism and bactericidal response to microorganisms.
• Diagnostic Complement
  Offers testing to determine the level and function of all complement components and split products. The laboratory offers quantitation of complement activation in vitro and in vivo. The Complement Laboratory has worked very extensively with pharmaceutical and biomaterials corporations in pre-clinical and clinical trials.
• Infectious Disease Pharmacokinetics
  IDPL offers analytical chemistry and pharmacokinetic modeling services with emphasis in infectious diseases. Study designs are routinely customized to meet individual researchers criteria. IDPL currently offers comprehensive antimycobacterial, antifungal and anti-HIV drug serum concentrations utilizing HPLC and GC assays. The IDPL laboratory also provides PK data analysis and has been providing services for pre-clinical and Phase I-IV clinical trials for over 15 years.
• Mycobacteriology
  Mycobacteriology offers bacteriological support for clinical trials to evaluate the efficacy of new drugs in the treatment, prevention of tuberculosis and M. avium infections as well as preclinical evaluation of experimental compounds against these infections. The Mycobacteriology Laboratory has developed drug susceptibility tests with new agents in accordance with FDA requirements and evaluation of new devices and systems for cultivation.
• Core Laboratory
  The Core Laboratory serves as a centralized laboratory in providing pre-screening and follow up testing for pharmaceutical clinical trials.

The National Jewish Clinical Reference Laboratory Directors are experts in developing customized assays as needed by our clients. In addition, they offer unprecedented personal consultation and interpretation for all assays performed at National Jewish Clinical Laboratories. Our laboratories perform numerous unique assays, many of which are not usually performed by other laboratories in the industry.

CAP
CLIA
JCAHO
Florida
New York
Pennsylvania

Pre-clinical trials, in vitro studies and other studies can be performed under 21 CFR Part 58 GLP requirements including audit and reporting.

The National Jewish campus is located on approximately 14 acres in Denver, Colorado The campus houses patient care areas, research laboratories the clinical reference laboratories and administrative offices.

Contact Information

National Jewish Clinical Reference Laboratories
Wendy Neuberger, Business & Marketing Manager
1400 Jackson St.
Denver, CO 80206 USA
Phone: 800-550-6227
Fax: 303-270-2125
E-mail:

If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:
	Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.